Autoimmune and infectious skin diseases that target desmogleins
スポンサーリンク
概要
- 論文の詳細を見る
Desmosomes are intercellular adhesive junctions of epithelial cells that contain two major transmembrane components, the desmogleins (Dsg) and desmocollins (Dsc), which are cadherin-type cell–cell adhesion molecules and are anchored to intermediate filaments of keratin through interactions with plakoglobin and desmoplakin. Desmosomes play an important role in maintaining the proper structure and barrier function of the epidermis and mucous epithelia. Four Dsg isoforms have been identified to date, Dsg1–Dsg4, and are involved in several skin and heart diseases. Dsg1 and Dsg3 are the two major Dsg isoforms in the skin and mucous membranes, and are targeted by IgG autoantibodies in pemphigus, an autoimmune disease of the skin and mucous membranes. Dsg1 is also targeted by exfoliative toxin (ET) released by Staphylococcus aureus in the infectious skin diseases bullous impetigo and staphylococcal scalded skin syndrome (SSSS). ET is a unique serine protease that shows lock and key specificity to Dsg1. Dsg2 is expressed in all tissues possessing desmosomes, including simple epithelia and myocardia, and mutations in this gene are responsible for arrhythmogenic right ventricular cardiomyopathy/dysplasia. Dsg4 plays an important adhesive role mainly in hair follicles, and Dsg4 mutations cause abnormal hair development. Recently, an active disease model for pemphigus was generated by a unique approach using autoantigen-deficient mice that do not acquire tolerance against the defective autoantigen. Adoptive transfer of Dsg3−/− lymphocytes into mice expressing Dsg3 induces stable anti-Dsg3 IgG production with development of the pemphigus phenotype. This mouse model is a valuable tool with which to investigate immunological mechanisms of harmful IgG autoantibody production in pemphigus. Further investigation of desmoglein molecules will continue to provide insight into the unsolved pathophysiological mechanisms of diseases and aid in the development of novel therapeutic strategies with minimal side effects.(Communicated by Kimishige ISHIZAKA, M.J.A.)
著者
-
AMAGAI Masayuki
Department of Dermatology, Keio University School of Medicine
-
Amagai Masayuki
Department Of Dermatology Keio University School Of Medicine
関連論文
- Sequence analysis of filaggrin gene by novel shotgun method in Japanese atopic dermatitis
- Comparative study of autoantigen profile between Colombian and Brazilian types of endemic pemphigus foliaceus by various biochemical and molecular biological techniques
- A Case of Herpetiform Pemphigus with Anti-Desmoglein 3 IgG Autoantibodies
- Genetic characterization of human Dsg3-specific B cells isolated by flow cytometry from the peripheral blood of patients with pemphigus vulgaris
- BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid
- A case of generalized Hailey-Hailey disease with fatal liver injury
- Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180kD bullous pemphigoid antigen
- Pemphigus : from immunofluorescence to molecular biology
- Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen : implications for peripheral tolerance
- Auto-reactive B cells against peripheral antigen, desmoglein 3, escape from tolerance mechanism
- Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris
- Cloning of canine desmoglein 3 and immunoreactivity of serum antibodies in human and canine pemphigus vulgaris with its extracellular domains
- No involvement of IgG autoantibodies against extracellular domains of desmoglein 2 in paraneoplastic pemphigus or inflammatory bowel diseases
- Immune dysregulation of pemphigus in humans and mice
- Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus
- Thymoma with Pemphigus Foliaceus
- Experimental evaluation of ebastine, a second-generation antihistamine, as a supportive medication for alopecia areata
- No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes
- Autoimmune and infectious skin diseases that target desmogleins
- Staphylococcal exfoliative toxins : "Molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals
- Pemphigus as a paradigm of autoimmunity and cell adhesion
- Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation
- Subcellular localization of desmosomal components is different between desmoglein3 knockout mice and pemphigus vulgaris model mice
- Gene ontology analysis of human hair follicle bulge molecular signature
- Desmosome splitting is a primary ultrastructural change in the acantholysis of pemphigus
- Immunoreactivity against intracellular domains of desmogleins in pemphigus
- Autoimmunity against desmosomal cadherins in pemphigus
- Production of the entire extracellular domain of BP180 (type XVII collagen) by baculovirus expression
- JKCS2-3 Dissection of epidermal barrier function and its dysfunction in atopic diseases(Atopic eczema and related diseases,Symposium 2,Japan-Korea-China Joint Symposium)
- Transgenic rescue of desmoglein 3 null mice with desmoglein 1 to develop a syngeneic mouse model for pemphigus vulgaris
- Development of NC1 and NC2 domains of Type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients
- Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI)